These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2076380)

  • 1. The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.
    Tio RA; de Langen CD; de Graeff PA; van Gilst WH; Bel KJ; Wolters KG; Mook PH; van Wijngaarden J; Wesseling H
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):695-703. PubMed ID: 2076380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
    Ferrari R; Cargnoni A; Curello S; Ceconi C; Boraso A; Visioli O
    J Cardiovasc Pharmacol; 1992; 20(5):694-704. PubMed ID: 1280730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
    Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of early angiotensin-converting enzyme inhibition in a pig model of myocardial ischemia and reperfusion.
    van Wijngaarden J; Tobé TJ; Weersink EG; Bel KJ; de Graeff PA; de Langen CD; van Gilst WH; Wesseling H
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):408-16. PubMed ID: 1378122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
    Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
    Borghi C; Ambrosioni E;
    Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
    van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of zofenopril in myocardial protection during cardioplegia arrest: an isolated rat heart model.
    Leva C; Mariscalco G; Ferrarese S; Bruno VD; Orrù A; Cattaneo P; Sala A
    J Card Surg; 2006; 21(1):44-9. PubMed ID: 16426347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
    Zhu B; Sun Y; Sievers RE; Browne AE; Pulukurthy S; Sudhir K; Lee RJ; Chou TM; Chatterjee K; Parmley WW
    J Am Coll Cardiol; 2000 Mar; 35(3):787-95. PubMed ID: 10716484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of isradipine on hemodynamic parameters and ventricular tachycardia in healed myocardial infarction.
    de Langen CD; van den Toren EW; Tio RA; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):254-8. PubMed ID: 1689421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
    Ambrosioni E; Borghi C; Magnani B
    Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of captopril against ischemia/reperfusion-induced ventricular arrhythmias in vitro and in vivo.
    deGraeff PA; deLangen CD; van Gilst WH; Bel K; Scholtens E; Kingma JH; Wesseling H
    Am J Med; 1988 Mar; 84(3A):67-74. PubMed ID: 3064601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs.
    Tobé TJ; de Langen CD; Weersink EG; van Wijngaarden J; Bel KJ; de Graeff PA; van Gilst WH; Wesseling H
    J Cardiovasc Pharmacol; 1992 May; 19(5):732-40. PubMed ID: 1381771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Bigioni M; Evangelista S; Goso C; Manzini S; Maggi CA
    Eur J Pharmacol; 2001 Feb; 414(1):71-8. PubMed ID: 11230997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonist.
    Hohlfeld T; Braun M; Strobach H; Schrör K
    J Cardiovasc Pharmacol; 1994 Jun; 23(6):922-31. PubMed ID: 7523784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
    de Nigris F; D'Armiento FP; Somma P; Casini A; Andreini I; Sarlo F; Mansueto G; De Rosa G; Bonaduce D; Condorelli M; Napoli C
    Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
    Przyklenk K; Kloner RA
    Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.